Skip to main content
. Author manuscript; available in PMC: 2008 May 31.
Published in final edited form as: J Immunol Methods. 2007 Apr 5;323(1):11–23. doi: 10.1016/j.jim.2007.03.006

Figure 1.

Figure 1

Nonreducing SDS-PAGE profile of the KRN7000:mCD1d:PPD complex used for the immunization protocol. Lane 1 shows 1 μg of the glutaraldehyde cross-linked immunogen. The constituents used to make this preparation are run separately at lane 2 (PPD, 4 μg) and lane 3 (KRN7000-loaded mCD1d, not aldehyde-fixed, 1 μg). Positions of MW markers are shown on the right.